退行性二尖瓣病变中的功能性三尖瓣反流:生存的关键决定因素
该研究纳入5083例孤立性退行性二尖瓣反流(DMR)患者,诊断时用多普勒超声评估功能性三尖瓣反流(FTR)程度并分析长期结局。FTR中/重度独立关联更差的临床状态和显著增高的死亡风险,且中/重度FTR外科治疗严重不足。
要点
- FTR严重度与DMR患者长期生存独立相关,重度FTR adjusted HR 2.10。
- 肺动脉高压是FTR最强决定因素,房颤、高龄、女性等亦相关。
- 中/重度FTR在诊断后5年内接受瓣膜手术的比例很低,治疗不足。
核心结论
- 在大型DMR队列中,FTR常见且不仅与肺动脉高压相关,还与房颤等其他因素相关。
- FTR严重度越高,诊断时临床表现越重,长期死亡率显著更高且独立于所有混杂因素。
- 中度和甚至重度FTR治疗严重不足,需仔细评估、考虑三尖瓣手术并测试新的经导管治疗。
研究设计与样本
- 研究纳入2003-2011年诊断的孤立性DMR患者,要求三尖瓣叶结构正常、诊断时行前瞻性FTR分级和多普勒超声估测sPAP,并分析长期结局。
- 共5083例 eligible DMR患者,年龄63 ± 16岁,女性47%,EF 63 ± 7%,sPAP 35 ± 13 mmHg。
主要发现
- FTR分级: trivial 45%, mild 37%, moderate 15%, severe 3%。
- 随访全程生存率70%(69-72%)at 10 years;按FTR严重度:trivial 82%(80-84%),mild 69%(66-71%),moderate 51%(47-57%),severe 26%(19-35%),P < 0.0001。
- 全面调整后超额死亡持续存在:moderate FTR adjusted HR 1.40(1.18-1.67),severe FTR adjusted HR 2.10(1.63-2.70),P ≤ 0.01。
- 调整sPAP/右室功能后超额死亡持续(P < 0.0001);匹配后adjusted HR 2.08(1.50-2.89),P < 0.0001;对比预期生存risk ratio 1.79(1.48-2.16),P < 0.0001。
- 诊断后5年内瓣膜手术:severe DMR 73%(70-75%),moderate DMR 15%(13-17%);severe FTR仅26%(19-34%),moderate FTR仅6%(4-8%)。
关键数值与推荐
- 肺动脉高压(sPAP ≥ 50 mmHg)是FTR严重度最强决定因素;其他强决定因素包括高龄、女性、较低左室EF、DMR及尤其房颤(均P ≤ 0.002)。
- 中/重度FTR独立关联更重临床表现、更多水肿、更低每搏输出量和肾功能受损(P ≤ 0.01)。
临床怎么用
- 对DMR患者应仔细评估FTR严重度,中/重度FTR提示预后不良且当前治疗不足。
- 中/重度FTR患者应考虑三尖瓣手术,并探索新的经导管治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To assess functional tricuspid regurgitation (FTR) determinants, consequences, and independent impact on outcome in degenerative mitral regurgitation (DMR). METHODS AND RESULTS: All patients diagnosed with isolated DMR 2003-2011, with structurally normal tricuspid leaflets, prospective FTR grading and systolic pulmonary artery pressure (sPAP) estimation by Doppler echocardiography at diagnosis were identified and long-term outcome analysed. The 5083 DMR eligible patients [63 ± 16 years, 47% female, ejection fraction (EF) 63 ± 7%, and sPAP 35 ± 13 mmHg] presented with FTR graded trivial in 45%, mild in 37%, moderate in 15%, and severe in 3%. While pulmonary hypertension (PHTN-sPAP ≥ 50 mmHg) was the most powerful FTR severity determinant, other strong FTR determinants were older age, female sex, lower left ventricle EF, DMR, and particularly atrial fibrillation (AFib) (all P ≤ 0.002). Functional tricuspid regurgitation moderate/severe was independently linked to more severe clinical presentation, more oedema, lower stroke volume, and impaired renal function (P ≤ 0.01). Survival (95% confidence interval) throughout follow-up [70% (69-72%) at 10 years] was strongly associated with FTR severity [82% (80-84%) for trivial, 69% (66-71%) for mild, 51% (47-57%) for moderate, and 26% (19-35%) for severe, P < 0.0001]. Excess mortality persisted after comprehensive adjustment [adjusted hazard ratio 1.40 (1.18-1.67) for moderate FTR and 2.10 (1.63-2.70) for severe FTR, P ≤ 0.01]. Excess mortality persisted adjusting for sPAP/right ventricular function (P < 0.0001), by matching [adjusted hazard ratios 2.08 (1.50-2.89), P < 0.0001] and vs. expected survival [risk ratio 1.79 (1.48-2.16), P < 0.0001]. Within 5-year of diagnosis valve surgery was performed in 73% (70-75%) and 15% (13-17%) of severe and moderate DMR and in only 26% (19-34%) and 6% (4-8%) of severe and moderate FTR. Valvular surgery improved outcome without alleviating completely higher mortality associated with FTR (P < 0.0001). CONCLUSION: In this large DMR cohort, FTR was frequent and causally, not only linked to PHTN but also to other factors, particularly AFib. Higher FTR severity is associated at diagnosis with more severe clinical presentation. Long term, FTR is independently of all confounders, associated with considerably worse mortality. Functional tricuspid regurgitation moderate and even severe is profoundly undertreated. Thus careful assessment, consideration for tricuspid surgery, and testing of new transcatheter therapy is warranted.
引用
- Essayagh B, Antoine C, Benfari G, et al. Functional tricuspid regurgitation of degenerative mitral valve disease: a crucial determinant of survival. Eur Heart J. 2020. PMID: 32300779. doi:10.1093/eurheartj/ehaa192
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。